Quick Answer
ROCKWELL MEDICAL, INC. reported Diluted EPS of $0.15 per share (loss) for fiscal year 2025.
ROCKWELL MEDICAL, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.15 | -400.0% |
| 2024 | -$0.03 | +91.9% |
| 2023 | -$0.37 | +71.8% |
| 2022 | -$1.31 | +65.8% |
| 2021 | -$3.83 | -834.1% |
| 2020 | -$0.41 | +19.6% |
| 2017 | -$0.51 | -30.8% |
| 2016 | -$0.39 | -34.5% |
| 2015 | -$0.29 | +44.2% |
| 2014 | -$0.52 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.05 | -225.0% | +0.0% |
| June 30, 2025 | -$0.05 | -600.0% | -25.0% |
| March 31, 2025 | -$0.04 | +33.3% | -200.0% |
| September 30, 2024 | $0.04 | +157.1% | +300.0% |
| June 30, 2024 | $0.01 | +105.6% | +116.7% |
| March 31, 2024 | -$0.06 | +40.0% | +14.3% |
| September 30, 2023 | -$0.07 | +69.6% | +61.1% |
| June 30, 2023 | -$0.18 | +58.1% | -80.0% |
- ROCKWELL MEDICAL, INC. showed a decrease of -400.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2014–2025 period, ROCKWELL MEDICAL, INC.’s diluted eps has grown by 71.2% (from $0.52 per share (loss) to $0.15 per share (loss)).
- The most recent figure is from ROCKWELL MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: